Physician

Brooke Gillett, D.O.

According to 2025 Medicare claims, Brooke Gillett, D.O. (NPI: 1356538003) practices hematology/oncology in the Springfield, MO market, with the plurality of this provider's patient population coming from Greene, MO. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 65807-5230.

Gillett's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 526 traditional Medicare patients, billed 73,204 HCPCS/CPT codes, and received $1,586,667 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,894 prescription claims across 316 beneficiaries totaling $4,740,049 in drug costs, led by Kisqali (Ribociclib Succinate). DME data shows 11 claims. Open Payments data shows 35 records totaling $852. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,084,497 to $4,740,049. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $11,766 to $586.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$893K$1.8M2015 Medicare payment: $1,389,635 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,470,777 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,615,671 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,740,021 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,785,900 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,698,660 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,396,309 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,409,270 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,695,650 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,586,667 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201553376,525$1,389,635
2016644122,060$1,470,777
2017566148,437$1,615,671
2018627104,538$1,740,021
201961695,250$1,785,900
202050674,873$1,698,660
202149057,468$1,396,309
202251482,235$1,409,270
202351992,218$1,695,650
202452673,204$1,586,667

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.4M$4.7M2015 Drug cost: $1,084,497 (USD; Tot_Drug_Cst)2016 Drug cost: $1,900,423 (USD; Tot_Drug_Cst)2017 Drug cost: $2,166,190 (USD; Tot_Drug_Cst)2018 Drug cost: $2,456,011 (USD; Tot_Drug_Cst)2019 Drug cost: $1,506,832 (USD; Tot_Drug_Cst)2020 Drug cost: $2,435,565 (USD; Tot_Drug_Cst)2021 Drug cost: $2,886,439 (USD; Tot_Drug_Cst)2022 Drug cost: $3,554,522 (USD; Tot_Drug_Cst)2023 Drug cost: $3,527,637 (USD; Tot_Drug_Cst)2024 Drug cost: $4,740,049 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153382,271$1,084,497
20163302,552$1,900,423
20173472,368$2,166,190
20183232,554$2,456,011
20192901,883$1,506,832
20203172,061$2,435,565
20213282,120$2,886,439
20222981,923$3,554,522
20233372,094$3,527,637
20243161,894$4,740,049

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$20K$41K2015 Medicare payment: $40,603 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $21,211 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $10,486 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,539 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,230 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $4,165 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,032 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,025 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $441 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201545291$40,603
20161890$21,211
20171454$10,486
2018N/R35$2,539
20191354$5,230
2020N/RN/RN/R
2021N/R70$4,165
2022N/R14$1,032
2023N/R14$1,025
2024N/R11$441

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more264664$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more186243$57
80053Blood test, comprehensive group of blood chemicals130331$10
36415Insertion of needle into vein for collection of blood sample324765$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count345965$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KisqaliRibociclib Succinate621,736$746,485
RevlimidLenalidomide37987$716,238
ImbruvicaIbrutinib431,204$700,635
IbrancePalbociclib26728$402,141
TasignaNilotinib Hcl21588$305,971

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1392Portable oxygen concentrator, rentalYN/R11$441

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.35$852AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Brooke Gillett, D.O.?

Tedicare shows public-source Medicare data for Brooke Gillett, D.O. (NPI 1356538003), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brooke Gillett, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brooke Gillett, D.O.?

Brooke Gillett, D.O. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Brooke Gillett, D.O. have Open Payments data?

Brooke Gillett, D.O. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.